To save money, many people with ADHD take generic medications. Most have received assurances from their physicians that “bioequivalence” with the brand-name version is required and assured. Unfortunately, that is not always the case. Increasingly, patients who do notice a significant difference between brand-name and generic are making their voices heard.
The ADHD Roller Coaster covered this topic a few months ago, after I read an outrageous Consumer Reports press release that even warned consumers away from brand-name medications for ADHD as being too costly and unnecessary. I countered with this blog post on the potential dangers of generic medications for treating ADHD and co-existing conditions.
With other readers, I left comments at the Consumer Reports blog post (“Parents: Don’t rush Children to Adderall, Concerta, Strattera”).
Today’s New York Times article (“Not All Drugs Are the Same After All”) today backs up my points on generics. Some snippets: Read the rest of this entry »
Recent Comments